Silence Therapeutics PLC ADR Annual stock financials by MarketWatch. View the latest SLN financial statements, income statements and financial ratios.
Wild theory claims the world actually ended in 2012... and we are now living in the apocalypse chaos
A shocking theory that claims our world ended in 2012, and humanity has been living in a simulation ever since, has regained online popularity. The theory was born out of the ancient prophecy ...
To get a sense of who is truly in control of Silence Therapeutics plc (NASDAQ:SLN), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of ...
Some of Julia Donaldson and Axel Scheffler’s most popular characters are set to appear on BBC One and BBC iPlayer in three brand new idents this Christmas. The festive visuals will showcase a range of ...
The idents feature much-loved characters from the magical adaptations of Julia Donaldson and Axel Scheffler’s picture books Magic Light Pictures have created three charming new idents exclusively for ...
Magic Light Pictures have created three charming new idents exclusively for BBC One and BBC iPlayer commissioned especially for this festive season. The idents feature much-loved characters from the ...
One thing we could say about the analysts on Silence Therapeutics plc (NASDAQ:SLN) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the ...
Writing from the Chicagoland area in Illinois, Robert is an avid movie watcher and will take just about any excuse to find time to go to his local movie theaters. Robert graduated from Bradley ...
All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here. It's my pleasure to introduce the ...
The Melanoma Institute of Australia (MIA) previously developed a risk calculator for sentinel lymph node (SLN) metastasis risk to help clinicians and patients with primary cutaneous melanoma decide ...
The latest price target for Silence Therapeutics (NASDAQ:SLN) was reported by HC Wainwright & Co. on September 16, 2025. The analyst firm set a price target for $75.00 expecting SLN to rise to within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results